Allergan Response To Valeant Takeover Bid
Remember 2007? It was the year the first domino fell in what became a nasty wave of restructuring across the pharmaceutical industry that shed thousands of jobs in Canada and tens of thousands more across the globe. We may be in for another wave, albeit a smaller one.
In 2006, then CEO Jeff Kindler hailed torcetrapib as “…one of the most important compounds of our generation…”.
That never happened.
Find out how Environics can help your organization
Related insights
In this Q&A, Kosta provides a glimpse into his Environics journey, highlighting the impact of company culture, his passion for healthcare, and the continuous pursuit of growth—both professional and personal.
A reflection on key trends in 2023 and how they may shape the year ahead including healthcare, housing, democracy, climate, politics, and AI.
For Digital Health Week, Ahsan Sadiq and Sabrina Atwal reflect on Digital Health innovation and adoptions, as well as the importance of communicating it effectively.
Toronto
366 Adelaide Street West
Suite 101, Toronto, ON
Canada M5V 1R9
416 920 9010
Ottawa
116 Albert St
Suite 300, Ottawa, ON
Canada K1P 5G3
613 230 5089
Calgary
421 7th Ave SW
Suite 3000, Calgary, AB
Canada T2P 4K9
403 613 5735